The Regulation of Gene Expression via Epigenetic Mechanisms during Onset of Obesity, Type 2 Diabetes

肥胖、2 型糖尿病发病期间通过表观遗传机制调节基因表达

基本信息

  • 批准号:
    9270051
  • 负责人:
  • 金额:
    $ 10.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-05-05 至 2020-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): During the last a few decades, obesity and obesity related type 2 diabetes have become serious health problems worldwide. Obesity among both adults and children has significantly increased since 1990. During such a short period of time, genetic coding of human beings cannot be changed so significantly by evolution. Studies in chronic complex disorders such as obesity/type 2 diabetes are shifting the emphasis from genetic causative factors to epigenetic and environmental effects. Environmental factors including diets and lifestyles may play an important role in development of obesity/type 2 diabetes by influencing the epigenetic modifications to the human genome. It has been demonstrated recently that circulating fatty acids are associated with adiposity, insulin resistance, and muscle cell death. Now, the key question is what actual factors in adipocytes and muscle cells induced by fatty acids are mediating adiposity, insulin resistance, and muscle cell death. It is very likely each of the problems may be a result of regulation of more than one gene by fatty acids. Our preliminary data indicated that both saturated fatty acids and polyunsaturated fatty acids induced lipid accumulation in differentiated adipocytes while saturated fatty acids differentially affected adipocytes and muscles cells. The proposed project systematically addresses these questions using both adipocytes and muscle cells from the aspect of epigenetics. Aim 1 will identify the genes that are essential for lipid accumulation and insulin resistance in adipocytes. The genes that are essential for lipid accumulation should be the genes that are regulated by saturated fatty acids and unsaturated fatty acids in the same manner since both types of fatty acids cause significant lipid accumulation in differentiated adipocytes. The genes that are related with insulin resistance in differentiated adipocytes should be regulated by saturated fatty acids and polyunsaturated fatty acids in opposite manners since the two types of fatty acids have different effects on insulin resistance in differentiated adipocytes. Aim 2 will identify the genes essential for mediating cell death and insulin resistance in muscle cells. The genes that are mediating muscle cell death and insulin resistance should be regulated by saturated fatty acids and polyunsaturated fatty acids in opposite manners in muscle cells since these two types of fatty acids have different effects on muscle cell death and insulin resistance in muscle cells according to our preliminary data. Aim 3 will determine if epigenetic modifications are involved in mediating expression of genes identified in Aim 1&2. Studies in this Aim will be mainly focused on methylation and microRNAs. This project may directly lead to identification of potential drug targets. This project will also provide opportuniies for 2 graduate and 10 undergraduate Hispanic students to experience biomedical research.
 描述(由适用提供):在过去的几十年中,肥胖和肥胖与2型糖尿病有关,已成为全球严重的健康问题。自1990年以来,成人和儿童的肥胖症都显着增加。在如此短的时间内,人类的基因编码不能通过进化而显着改变。诸如肥胖/2型糖尿病之类的慢性复合疾病的研究正在将重点从遗传严重因素转变为表观遗传和环境影响。包括饮食和生活方式在内的环境因素可能通过影响对人类基因组的表观遗传学修饰来在肥胖/2型糖尿病的发展中起重要作用。最近已经证明,循环脂肪酸与肥胖,胰岛素抵抗和肌肉细胞死亡有关。现在,关键问题是脂肪酸诱导的脂肪细胞和肌肉细胞中哪些实际因素是介导肥胖,胰岛素抵抗和肌肉细胞死亡。每个问题很可能是通过脂肪酸调节多个基因的结果。我们的初步数据表明,饱和脂肪酸和多不饱和脂肪酸都会诱导分化脂肪细胞中的脂质积累,而饱和脂肪酸对脂肪酸的影响不同。拟议的项目从表观遗传学方面使用脂肪细胞和肌肉细胞系统地解决了这些问题。 AIM 1将识别脂肪细胞中脂质积累和胰岛素抵抗至关重要的基因。脂质积累必不可少的基因应是由饱和脂肪酸和不饱和脂肪酸以相同方式调节的基因,因为两种类型的脂肪酸都会在分化的脂肪细胞中引起明显的脂质积累。 AIM 2将鉴定介导细胞死亡必不可少的基因,胰岛素抵抗应受到相反的方式的饱和脂肪酸和多不饱和脂肪酸的调节,因为两种类型的脂肪酸对分化脂肪细胞中胰岛素抵抗具有不同的影响。 AIM 2将确定介导细胞死亡和胰岛素抵抗至关重要的基因 在肌肉细胞中。介导肌肉细胞死亡和胰岛素抵抗的基因应由肌肉细胞中相反界限的饱和脂肪酸和多不饱和脂肪酸调节,因为这两种类型的脂肪酸对肌肉细胞死亡和胰岛素耐药性具有不同的影响,根据我们的初步数据。 AIM 3将确定表观遗传修饰是否参与AIM 1和2中鉴定的基因表达的介导。该目标的研究将主要集中在甲基化和microRNA上。该项目可能直接导致对潜在药物靶标的识别。该项目还将为2名研究生和10位西班牙裔学生提供机会体验生物医学研究的机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yi Li其他文献

Yi Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yi Li', 18)}}的其他基金

Lactation on Breast Tumorigenesis
哺乳期对乳腺肿瘤发生的影响
  • 批准号:
    10668820
  • 财政年份:
    2023
  • 资助金额:
    $ 10.32万
  • 项目类别:
Mutating E-cadherin in rats to model lobular breast cancer
突变大鼠 E-钙粘蛋白以模拟小叶乳腺癌
  • 批准号:
    10830164
  • 财政年份:
    2022
  • 资助金额:
    $ 10.32万
  • 项目类别:
Next Generation Rat Models of ER+ Breast Cancer
下一代 ER 乳腺癌大鼠模型
  • 批准号:
    10591512
  • 财政年份:
    2022
  • 资助金额:
    $ 10.32万
  • 项目类别:
Next Generation Rat Models of ER+ Breast Cancer
下一代 ER 乳腺癌大鼠模型
  • 批准号:
    10464834
  • 财政年份:
    2022
  • 资助金额:
    $ 10.32万
  • 项目类别:
New Statistical Methods for Modelling Cancer Outcomes
癌症结果建模的新统计方法
  • 批准号:
    10542801
  • 财政年份:
    2021
  • 资助金额:
    $ 10.32万
  • 项目类别:
New Statistical Methods for Modelling Cancer Outcomes
癌症结果建模的新统计方法
  • 批准号:
    10317123
  • 财政年份:
    2021
  • 资助金额:
    $ 10.32万
  • 项目类别:
CSF Clearance in Sporadic Alzheimer's Disease
散发性阿尔茨海默病的脑脊液清除率
  • 批准号:
    10606516
  • 财政年份:
    2019
  • 资助金额:
    $ 10.32万
  • 项目类别:
CSF Clearance in Sporadic Alzheimer's Disease
散发性阿尔茨海默病的脑脊液清除率
  • 批准号:
    9981182
  • 财政年份:
    2019
  • 资助金额:
    $ 10.32万
  • 项目类别:
CSF Clearance in Sporadic Alzheimer's Disease
散发性阿尔茨海默病的脑脊液清除率
  • 批准号:
    9993210
  • 财政年份:
    2019
  • 资助金额:
    $ 10.32万
  • 项目类别:
CSF Clearance in Sporadic Alzheimer's Disease
散发性阿尔茨海默病的脑脊液清除率
  • 批准号:
    10390277
  • 财政年份:
    2019
  • 资助金额:
    $ 10.32万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Trimming the fat with small proteins: Micropeptides in adipogenesis
用小蛋白质减少脂肪:脂肪生成中的微肽
  • 批准号:
    10655394
  • 财政年份:
    2022
  • 资助金额:
    $ 10.32万
  • 项目类别:
The Role of eIF4G1 and eIF4G2 in Translational Control of Adipogenesis and Obesity
eIF4G1 和 eIF4G2 在脂肪生成和肥胖转化控制中的作用
  • 批准号:
    10625835
  • 财政年份:
    2022
  • 资助金额:
    $ 10.32万
  • 项目类别:
The Role of eIF4G1 and eIF4G2 in Translational Control of Adipogenesis and Obesity
eIF4G1 和 eIF4G2 在脂肪生成和肥胖转化控制中的作用
  • 批准号:
    10464460
  • 财政年份:
    2022
  • 资助金额:
    $ 10.32万
  • 项目类别:
Mechanisms of Environmental-Mixture Induced Metabolic Disruption
环境混合物引起的代谢紊乱的机制
  • 批准号:
    10225688
  • 财政年份:
    2020
  • 资助金额:
    $ 10.32万
  • 项目类别:
Mechanisms of adipocyte loss in laminopathy-induced lipodystrophy in mice and humans
小鼠和人类核纤层病诱导的脂肪营养不良中脂肪细胞损失的机制
  • 批准号:
    10447012
  • 财政年份:
    2020
  • 资助金额:
    $ 10.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了